EVO Human Performance is a Greece-based startup that has set out to revolutionize the sports industry with its AI-powered bioengineering solutions. The company’s flagship software, artemYs, integrates computational fluid mechanics, finite element analysis, and deep learning to provide personalized insights into the myoskeletal system, setting a new standard in performance monitoring and injury prevention.
EVO Human Performance has already made significant inroads in the sports industry, working with elite football and basketball clubs in top European competitions, as well as elite academies. Their tailored solutions have gained the trust of high-profile athletes, aiding in rehabilitation and safe return to play post-injury. Additionally, the company’s player profiling report has become a valuable tool for players and clubs during the recruitment process.
Founded in 2021, EVO Human Performance is at the forefront of leveraging AI and technology to empower athletes and teams in achieving peak performance and maintaining optimal health. With a focus on individualized workload management and myoskeletal analysis, the startup is positioning itself as a key player in the future of sports technology.
EVO Human Performance presents a promising opportunity for investors seeking to tap into the intersection of sports, technology, and AI-driven solutions. As the company continues to make strides in the industry, potential investors should keep a close watch on its growth trajectory and the impact of its innovative offerings on the sports landscape.